ReP USP - Resultado da busca

Artigo de periodico
Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair (2017)
Alex, Alexandra Khichfy; Siqueira, Sheila; Coundry, Renata; Santos, Juliana; Alves, Michel; Hoff, Paulo Marcelo Gehm; Riechelmann, Rachel P.
Source: Clinical Colorectal Cancer. Unidade: FM
Subjects: DNA, PROGNÓSTICO, NEOPLASIAS COLORRETAIS, FISIOPATOLOGIA, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALEX, Alexandra Khichfy et al. Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair. Clinical Colorectal Cancer, v. 16, n. 3, p. 228-239, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2016.11.001. Acesso em: 05 nov. 2024.
APA
Alex, A. K., Siqueira, S., Coundry, R., Santos, J., Alves, M., Hoff, P. M. G., & Riechelmann, R. P. (2017). Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair. Clinical Colorectal Cancer, 16( 3), 228-239. doi:10.1016/j.clcc.2016.11.001
NLM
Alex AK, Siqueira S, Coundry R, Santos J, Alves M, Hoff PMG, Riechelmann RP. Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair [Internet]. Clinical Colorectal Cancer. 2017 ; 16( 3): 228-239.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2016.11.001
Vancouver
Alex AK, Siqueira S, Coundry R, Santos J, Alves M, Hoff PMG, Riechelmann RP. Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair [Internet]. Clinical Colorectal Cancer. 2017 ; 16( 3): 228-239.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2016.11.001
Artigo de periodico
Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community (2017)
Protásio, Bruno Mendonça; Matutino, Adriana; Lage, Liana Valente; Santana, Iuri; Ramos, Ricardo; Sabbaga, Jorge; Capareli, Fernanda; Saragiotto, Daniel; Riechelmann, Rachel P.; Hoff, Paulo M.
Source: Clinical Colorectal Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, QUIMIOTERAPIA ADJUVANTE, ANTINEOPLÁSICOS, AVANÇO DA DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PROTÁSIO, Bruno Mendonça et al. Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community. Clinical Colorectal Cancer, v. 16, n. 1, p. 65-72, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2016.07.001. Acesso em: 05 nov. 2024.
APA
Protásio, B. M., Matutino, A., Lage, L. V., Santana, I., Ramos, R., Sabbaga, J., et al. (2017). Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community. Clinical Colorectal Cancer, 16( 1), 65-72. doi:10.1016/j.clcc.2016.07.001
NLM
Protásio BM, Matutino A, Lage LV, Santana I, Ramos R, Sabbaga J, Capareli F, Saragiotto D, Riechelmann RP, Hoff PM. Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community [Internet]. Clinical Colorectal Cancer. 2017 ; 16( 1): 65-72.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2016.07.001
Vancouver
Protásio BM, Matutino A, Lage LV, Santana I, Ramos R, Sabbaga J, Capareli F, Saragiotto D, Riechelmann RP, Hoff PM. Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community [Internet]. Clinical Colorectal Cancer. 2017 ; 16( 1): 65-72.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2016.07.001
Artigo de periodico
The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients With an ECOG Performance Status of 3 and 4 (2015)
Teixeira, Marcela Crosara; Marques, Daniel Fernandes; Ferrari, Anezka Celis; Alves, Michel Fabiano Silva; Alex, Alexandra Khichfy; Sabbaga, Jorge; Hoff, Paulo M.; Riechelmann, Rachel P.
Source: Clinical Colorectal Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (QUIMIOTERAPIA), METÁSTASE NEOPLÁSICA, CUIDADOS PALIATIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Marcela Crosara et al. The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients With an ECOG Performance Status of 3 and 4. Clinical Colorectal Cancer, v. 14, n. 1, p. 52-57, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2014.09.010. Acesso em: 05 nov. 2024.
APA
Teixeira, M. C., Marques, D. F., Ferrari, A. C., Alves, M. F. S., Alex, A. K., Sabbaga, J., et al. (2015). The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients With an ECOG Performance Status of 3 and 4. Clinical Colorectal Cancer, 14( 1), 52-57. doi:10.1016/j.clcc.2014.09.010
NLM
Teixeira MC, Marques DF, Ferrari AC, Alves MFS, Alex AK, Sabbaga J, Hoff PM, Riechelmann RP. The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients With an ECOG Performance Status of 3 and 4 [Internet]. Clinical Colorectal Cancer. 2015 ; 14( 1): 52-57.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2014.09.010
Vancouver
Teixeira MC, Marques DF, Ferrari AC, Alves MFS, Alex AK, Sabbaga J, Hoff PM, Riechelmann RP. The Effects of Palliative Chemotherapy in Metastatic Colorectal Cancer Patients With an ECOG Performance Status of 3 and 4 [Internet]. Clinical Colorectal Cancer. 2015 ; 14( 1): 52-57.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2014.09.010
Artigo de periodico
Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities (2013)
Ferrarotto, Renata; Hoff, Paulo Marcelo Gehm
Source: Clinical Colorectal Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, METÁSTASE NEOPLÁSICA, HIPERTENSÃO, QUIMIOTERÁPICOS (EFEITOS), TROMBOEMBOLISMO, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAROTTO, Renata e HOFF, Paulo Marcelo Gehm. Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities. Clinical Colorectal Cancer, v. 12, n. 1, p. 1-7, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2012.06.002. Acesso em: 05 nov. 2024.
APA
Ferrarotto, R., & Hoff, P. M. G. (2013). Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities. Clinical Colorectal Cancer, 12( 1), 1-7. doi:10.1016/j.clcc.2012.06.002
NLM
Ferrarotto R, Hoff PMG. Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities [Internet]. Clinical Colorectal Cancer. 2013 ; 12( 1): 1-7.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2012.06.002
Vancouver
Ferrarotto R, Hoff PMG. Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities [Internet]. Clinical Colorectal Cancer. 2013 ; 12( 1): 1-7.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2012.06.002
Artigo de periodico
Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity (2012)
Hoff, Paulo M.; Saad, Everardo D.; Costa, Frederico; Coutinho, Anelisa K.; Caponero, Ricardo; Prolla, Gabriel; Gansl, Rene C.
Source: Clinical Colorectal Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), DROGATERAPIA (TOXIDADE), METÁSTASE NEOPLÁSICA, ANTINEOPLÁSICOS (TOXIDADE), MANIFESTAÇÕES NEUROLÓGICAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOFF, Paulo M. et al. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer, v. 11, n. 2, p. 93-100, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2011.10.004. Acesso em: 05 nov. 2024.
APA
Hoff, P. M., Saad, E. D., Costa, F., Coutinho, A. K., Caponero, R., Prolla, G., & Gansl, R. C. (2012). Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer, 11( 2), 93-100. doi:10.1016/j.clcc.2011.10.004
NLM
Hoff PM, Saad ED, Costa F, Coutinho AK, Caponero R, Prolla G, Gansl RC. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity [Internet]. Clinical Colorectal Cancer. 2012 ; 11( 2): 93-100.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2011.10.004
Vancouver
Hoff PM, Saad ED, Costa F, Coutinho AK, Caponero R, Prolla G, Gansl RC. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity [Internet]. Clinical Colorectal Cancer. 2012 ; 11( 2): 93-100.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2011.10.004
Artigo de periodico
Unilateral Hand-Foot Syndrome: Does It Take Sides? Case Report and Literature Review (2012)
Cruz, Livia Almeida da; Hoff, Paulo Marcelo Gehm; Ferrari, Claudio Luiz Seabra; Riewchelmann, Rachel Simões Pimenta
Source: Clinical Colorectal Cancer. Unidade: FM
Subjects: ACIDENTE VASCULAR CEREBRAL, METÁSTASE NEOPLÁSICA, LATERALIDADE, MÃO (FISIOPATOLOGIA), PÉ (FISIOPATOLOGIA), NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, Livia Almeida da et al. Unilateral Hand-Foot Syndrome: Does It Take Sides? Case Report and Literature Review. Clinical Colorectal Cancer, v. 11, n. 1, p. 82-84, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2011.05.004. Acesso em: 05 nov. 2024.
APA
Cruz, L. A. da, Hoff, P. M. G., Ferrari, C. L. S., & Riewchelmann, R. S. P. (2012). Unilateral Hand-Foot Syndrome: Does It Take Sides? Case Report and Literature Review. Clinical Colorectal Cancer, 11( 1), 82-84. doi:10.1016/j.clcc.2011.05.004
NLM
Cruz LA da, Hoff PMG, Ferrari CLS, Riewchelmann RSP. Unilateral Hand-Foot Syndrome: Does It Take Sides? Case Report and Literature Review [Internet]. Clinical Colorectal Cancer. 2012 ; 11( 1): 82-84.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2011.05.004
Vancouver
Cruz LA da, Hoff PMG, Ferrari CLS, Riewchelmann RSP. Unilateral Hand-Foot Syndrome: Does It Take Sides? Case Report and Literature Review [Internet]. Clinical Colorectal Cancer. 2012 ; 11( 1): 82-84.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.clcc.2011.05.004

USP Schools

ReP

Filtros

Authors

Subjects